|
American College of Radiology Imaging Network
|
5U01CA080098-09
|
$10,637,601
|
HILLMAN, BRUCE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Provoking anti-tumor immune responses with Fas ligand
|
5R43CA119840-02
|
$335,358
|
BELLGRAU, DONALD
|
APOPLOGIC PHARMACEUTICALS, LLC
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
SPORE in Lymphoma
|
1P50CA126752-01
|
$2,266,618
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Genomic Profile-Based Prognostic Markers for Ependymoma
|
5R33CA097874-05
|
$528,774
|
Lau, Ching
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Novel Strategies for Immunotherapy fo Cancer
|
5R01CA101795-04
|
$263,284
|
Wang, Rongfu
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of Mitochondrial DNA Alterations in Cancer
|
5R01CA100023-04
|
$291,567
|
Wong, Lee-Jun
|
BAYLOR COLLEGE OF MEDICINE
|
|
Signal Transduction by Non-transmembrane PTPs
|
5R37CA049152-19
|
$502,926
|
NEEL, BENJAMIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Long Acting VEGF BInding Proteins for Treating Cancer
|
5R44CA099217-03
|
$335,148
|
Cox, George
|
BOLDER BIOTECHNOLOGY, INC.
|
|
VHL, Jade-1 and protein stability in renal cancer
|
5R01CA079830-08
|
$305,314
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
Pathogenesis of NUT-Rearranged Carcinoma
|
1R01CA124633-01
|
$299,250
|
French, Christopher
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation
|
2R01CA047006-20A2
|
$538,386
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus LMP-1 Mediated Oncongenicity
|
5R01CA085180-07
|
$744,728
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Pathogenesis of Epstein-Barr Virus Infection
|
5R01CA068051-12
|
$403,843
|
WANG, FREDERICK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
CENTRAL INSTITUTIONAL REVIEW BOARD (CIRB) INITIATIVE
|
N02CM522011-005
|
$2,318,600
|
OLSON, DOROTHY
|
CAPITAL TECHNOLOGY INFORMATION SERVICES,
|
|
Functional analysis of signaling to and from p53 in ca
|
5R01CA098916-06
|
$258,227
|
AGARWAL, Munna
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Variation in Ara-C Pathway Genes and Treatment Outcomes in AML
|
1R21CA119142-01A1
|
$164,365
|
GOYAL, RAKESH
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
|
GENOMIC ANALYSIS OF MEDULLOBLASTOMAS
|
5R01CA109467-04
|
$740,333
|
POMEROY, SCOTT
|
CHILDREN'S HOSPITAL BOSTON
|
|
Brain tumor angiogenesis: Integrin ceramide signaling
|
5R01CA098568-04
|
$266,432
|
ERDREICH-EPSTEIN, ANAT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Novel Ceramide-based Chemotherapy for Acute Leukemia
|
5R01CA100895-04
|
$236,830
|
MAURER, BARRY
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Localization and Function of iNKT Cells in Neuroblastoma
|
5R01CA116548-03
|
$228,165
|
METELITSA, LEONID
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Enhancing Activity of Alkylating Agents in Neuroblastoma
|
5R01CA082830-06
|
$62,346
|
REYNOLDS, CHARLES
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Clinical Correlative Studies of Neuroblastoma
|
2R01CA060104-14A1
|
$408,898
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Biology and Therapy of High Risk Neuroblastoma
|
5P01CA081403-08
|
$1,899,503
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Diagnostic and Prognostic Sarcoma Signatures
|
5U01CA114757-03
|
$1,657,644
|
Triche, Timothy
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Oncolytic HSV Therapy in Immunocompetent Sarcoma Models
|
5R01CA114004-02
|
$258,529
|
CRIPE, TIMOTHY
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Promoting Treatment Adherence in Adolescent Leukemia
|
1R01CA119162-01A1
|
$701,307
|
DROTAR, DENNIS
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Role of Nucleophosmin in FA-evolved Leukemia
|
5R01CA109641-04
|
$289,623
|
PANG, QISHEN
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Molecular Studies of Down Syndrome Leukemia
|
5R01CA111778-03
|
$231,698
|
PERENTESIS, JOHN
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Neurobehavioral Late-Effects in Pediatric Brain Tumors
|
5R01CA112182-03
|
$84,987
|
RIS, M
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Gene Transfer to Facilitate Dose-Intensification in the Treatment of Pediatric B*
|
5R21CA121578-02
|
$206,823
|
Wagner, Lars
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
5R01CA113969-03
|
$279,026
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Rac GTPases as Targets in Lymphomagenesis
|
1R01CA125658-01
|
$285,000
|
ZHENG, YI
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
|
5R01CA108862-03
|
$256,930
|
Aplenc, Richard
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Neuroblastoma Biology and Therapy
|
5P01CA097323-05
|
$2,216,467
|
BRODEUR, GARRETT
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Occupational Pesticide Exposure of Parents and Brain Tumor Risk in Children
|
1R03CA130028-01
|
$107,406
|
BUNIN, GRETA
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
CONTROL SELECTION METHODS FOR CHILDHOOD CANCER STUDIES
|
5R01CA108934-02
|
$374,780
|
BUNIN, GRETA
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
ANTINEOPLASTIC v LEUKEMOGENIC EPIPODOPHYLLOTOXIN EFFECTS
|
5R01CA077683-08
|
$266,610
|
Felix, Carolyn
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Determinants of Relapse Risk After BMT for ALL
|
1R01CA116660-01A2
|
$304,189
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
|
5R01CA102646-03
|
$308,531
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
PSYCHOLOGICAL OUTCOME IN CHILDHOOD CANCER SURVIVORS
|
5R01CA106928-04
|
$352,545
|
KAZAK, ANNE
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Developing a Measure of Voluntary Consent for Protocol-Based Treatment Decisions
|
5R21CA118377-02
|
$142,154
|
NELSON, ROBERT
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Development of CpG oligodeoxynucleotides as adjuvant chemotherapy for ALL
|
5R03CA123554-02
|
$80,108
|
Reid, Gregor
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
The Adverse Effect of Health on Personal Goal Pursuit in Adolescents with Cancer
|
5R03CA126337-02
|
$80,593
|
Schwartz, Lisa
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Sibling and Parent Bereavement from Childhood Cancer
|
5R01CA098217-03
|
$443,420
|
GERHARDT, CYNTHIA
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Gangliosides and the Biology of Human Neuroblastoma
|
5R01CA042361-16
|
$261,674
|
LADISCH, STEPHAN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Complex ganglioside function in neuroblastoma
|
5R01CA106532-03
|
$247,903
|
LADISCH, STEPHAN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
The Role of PDGFR in Medulloblastoma Progression
|
5R01CA111835-02
|
$257,494
|
MACDONALD, TOBEY
|
CHILDREN'S RESEARCH INSTITUTE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|